150 related articles for article (PubMed ID: 36503376)
1. Improving measures of disease activity in systemic lupus erythematosus.
Banjari M; Touma Z; Gladman DD
Expert Rev Clin Immunol; 2023 Feb; 19(2):193-202. PubMed ID: 36503376
[TBL] [Abstract][Full Text] [Related]
2. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS.
Koo M; Lu MC
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138199
[TBL] [Abstract][Full Text] [Related]
3. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
Ma J; Zhang L; Yan M; Liu Z; Xue L
Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38862157
[TBL] [Abstract][Full Text] [Related]
4. Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials.
Tofighi T; Morand EF; Touma Z
Rheum Dis Clin North Am; 2021 Aug; 47(3):415-426. PubMed ID: 34215371
[TBL] [Abstract][Full Text] [Related]
5. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
Castrejón I; Tani C; Jolly M; Huang A; Mosca M
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
[TBL] [Abstract][Full Text] [Related]
6. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
Abdelhady EI; Rabie M; Hassan RA
Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
[TBL] [Abstract][Full Text] [Related]
7. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
8. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
9. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
[TBL] [Abstract][Full Text] [Related]
10. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
11. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
Eudy AM; Reeve BB; Coles T; Lin L; Rogers JL; Pisetsky DS; Criscione-Schreiber LG; Doss J; Sadun R; Sun K; Clowse ME
Lupus; 2022 May; 31(6):697-705. PubMed ID: 35343853
[TBL] [Abstract][Full Text] [Related]
12. What is the best instrument to measure disease activity in SLE? - SLE-DAS vs Easy BILAG.
Inês LS; Fredi M; Jesus D; Shumilova A; Franceschini F; Vital EM
Autoimmun Rev; 2024 Jan; 23(1):103428. PubMed ID: 37634675
[TBL] [Abstract][Full Text] [Related]
13. Assessment of lupus: where are we now?
Hay E; Gordon C; Emery P
Ann Rheum Dis; 1993 Mar; 52(3):169-72. PubMed ID: 8484667
[TBL] [Abstract][Full Text] [Related]
14. Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda.
Liang MH; Fortin PR; Isenberg DA; Snaith L
Rheumatol Int; 1991; 11(3):133-6. PubMed ID: 1754816
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
Lai NS; Lu MC; Chang HH; Lo HC; Hsu CW; Huang KY; Tung CH; Hsu BB; Wu CH; Koo M
J Clin Med; 2021 May; 10(10):. PubMed ID: 34063379
[TBL] [Abstract][Full Text] [Related]
16. Assessment of disease activity and damage in SLE: Are we there yet?
Cruciani C; Zen M; Gatto M; Morand E; Doria A
Best Pract Res Clin Rheumatol; 2023 Dec; 37(4):101896. PubMed ID: 38044231
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
[TBL] [Abstract][Full Text] [Related]
18. Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus.
Gladman DD
Curr Opin Rheumatol; 1994 Sep; 6(5):487-92. PubMed ID: 7993706
[TBL] [Abstract][Full Text] [Related]
19. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.
FitzGerald JD; Grossman JM
Lupus; 1999; 8(8):638-44. PubMed ID: 10568901
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
Onishi A; Tsuji H; Takase Y; Nakakubo Y; Iwasaki T; Kozuki T; Yoshida T; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Yoshifuji H; Tanaka M; Morinobu A
Rheumatology (Oxford); 2023 Dec; 62(12):3909-3915. PubMed ID: 36943365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
